RATIONALE-315: EFS and OS of neoadjuvant tislelizumab (TIS) plus chemotherapy with adjuvant TIS in resectable NSCLC
Chair: Marina Garassino, USA, Presenter: Dongsheng Yue, China; Discussant: Luis Paz-Ares, Spain; AACR Expert Commentary: Justin Gainor, USA